Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization.
Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization
Each component has a specific meaning:
Note: Interpret the gsd-i monitor result against the thresholds and context described above.
Enter the glucose, lactate, uric acid, triglycerides, liver size for the scenario you are assessing. Monitors metabolic stability in Glycogen Storage Disease Type I using glucose, lactate, uric acid, triglycerides, and liver size, with cornstarch dosing optimization. Use the gsd-i monitor result to inform your calculation.